Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term outcome of ulcerative proctitis.

Literature DB >> 32741314

Long-term outcome of ulcerative proctitis.

Bella Ungar¹, Uri Kopylov¹.

Abstract

Entities: Disease

Mesh：

Substances：
Mesalamine

Year: 2020 PMID： 32741314 PMCID： PMC7707870 DOI： 10.1177/2050640620948795

Source DB: PubMed Journal: United European Gastroenterol J ISSN： 2050-6406 Impact factor: 4.623

× No keyword cloud information.

8 in total

1. Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.

Authors: Evelyne Dubois; Annick Moens; Rob Geelen; João Sabino; Marc Ferrante; Séverine Vermeire
Journal: United European Gastroenterol J Date: 2020-07-06 Impact factor: 4.623

2. Therapeutic requirements in active ulcerative proctitis: A single-centre study.

Authors: Margalida Calafat; Triana Lobatón; Míriam Mañosa; Laura Marín; Noemí Caballero; Macarena Larraín; Eduard Cabré; Eugeni Domènech
Journal: Gastroenterol Hepatol Date: 2017-06-27 Impact factor: 2.102

3. Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis.

Authors: Guillaume Pineton de Chambrun; Aurélien Amiot; Guillaume Bouguen; Stéphanie Viennot; Romain Altwegg; Edouard Louis; Michael Collins; Mathurin Fumery; Florian Poullenot; Laura Armengol; Anthony Buisson; Vered Abitbol; David Laharie; Philippe Seksik; Stéphane Nancey; Pierre Blanc; Yoram Bouhnik; Benjamin Pariente; Laurent Peyrin-Biroulet
Journal: Clin Gastroenterol Hepatol Date: 2019-06-13 Impact factor: 11.382

Review 4. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis.

Authors: Xian-rui Wu; Xiu-li Liu; Seymour Katz; Bo Shen
Journal: Inflamm Bowel Dis Date: 2015-03 Impact factor: 5.325

1 in total

1. Efficacy of the Panax Notoginseng Ejiao Suppository in the Treatment of Patients with Ulcerative Proctitis and Its Effect on Inflammatory Response and Immune Function.

Authors: Yu Liu; Yingjie Sun; Xince Wang; Dongsheng Wang; Li Zeng; Qingge Lu
Journal: Dis Markers Date: 2022-09-21 Impact factor: 3.464

1 in total

Long-term outcome of ulcerative proctitis.

1. Long-term outcomes of patients with ulcerative proctitis: Analysis from a large referral centre cohort.

2. Therapeutic requirements in active ulcerative proctitis: A single-centre study.

3. Efficacy of Tumor Necrosis Factor Antagonist Treatment in Patients With Refractory Ulcerative Proctitis.

Review 4. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis.

5. Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis.

6. Endoscopic progression of ulcerative proctitis to proximal disease. Can we identify predictors of progression?

Review 7. Drug therapies for ulcerative proctitis: systematic review and meta-analysis.

Review 8. Ulcerative proctitis: an update on the pharmacotherapy and management.

1. Efficacy of the Panax Notoginseng Ejiao Suppository in the Treatment of Patients with Ulcerative Proctitis and Its Effect on Inflammatory Response and Immune Function.